NIH R01 · 2024
PROJECT SUMMARY Alzheimer’s disease (AD) is a global crisis facing the aging population and society as a whole. Despite studies suggesting that blacks may be at greater risk of developing AD, with 2-3 times higher prevalence rate of cognitive impairment than whites, there have been few studies investigating racial disparities, and blacks have been under included in many prominent U.S. AD biomarker and clinical trials. The current biomarker classification system (i.e., the ATN model) may not fully account for racial disparity and can’t explain the increased prevalence in blacks of both AD and vascular risk factors for AD such as diabetes and hypertension when compared to whites. Research on…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.